Sodium Protects Against Nephrotoxicity in Patients Receiving Amphotericin B
- 1 November 1989
- journal article
- research article
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 298 (5) , 299-304
- https://doi.org/10.1097/00000441-198911000-00004
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Nephrotoxicity in Leukemic Patients Receiving Empirical Amphotericin B and AminoglycosidesSouthern Medical Journal, 1988
- Amphotericin-b nephrotoxicity in humans decreased by sodium supplements with coadministration of ticarcillin or intravenous salineJournal of Molecular Medicine, 1987
- Attenuation of experimental tobramycin nephrotoxicity by ticarcillinAntimicrobial Agents and Chemotherapy, 1985
- Amphotericin B nephrotoxicity in humans decreased by salt repletionThe American Journal of Medicine, 1983
- Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopeniaThe American Journal of Medicine, 1982
- SODIUM DEPLETION ENHANCES NEPHROTOXICITY OF AMPHOTERICIN BThe Lancet, 1981
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Interference with Feedback Control of Glomerular Filtration Rate by Furosemide, Triflocin, and CyanideJournal of Clinical Investigation, 1974
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958